These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37287044)

  • 1. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.
    Jo J; Kwon KT; Ko KS
    J Biomed Sci; 2023 Jun; 30(1):37. PubMed ID: 37287044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
    Jo J; Ko KS
    Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii.
    Çağlan E; Nigiz Ş; Sancak B; Gür D
    Acta Microbiol Immunol Hung; 2020 Jun; 67(2):107-111. PubMed ID: 31813259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development mechanism of resistant population post-exposure to tigecycline in tigecycline-heteroresistant Acinetobacter baumannii strain.
    Jo J; Park W; Kweon DH; Ko KS
    Int J Antimicrob Agents; 2023 Apr; 61(4):106739. PubMed ID: 36736497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two types of colistin heteroresistance in
    Hong YK; Kim H; Ko KS
    Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
    Ni W; Wang Y; Ma X; He Y; Zhao J; Guan J; Li Y; Gao Z
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1451-1457. PubMed ID: 36201141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital.
    Thet KT; Lunha K; Srisrattakarn A; Lulitanond A; Tavichakorntrakool R; Kuwatjanakul W; Charoensri N; Chanawong A
    World J Microbiol Biotechnol; 2020 Jul; 36(7):102. PubMed ID: 32613355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.
    Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T
    J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran.
    Ezadi F; Jamali A; Heidari A; Javid N; Ardebili A
    J Glob Antimicrob Resist; 2020 Jun; 21():380-385. PubMed ID: 31770604
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yin T; Lai JJ; Huang WC; Kuo SC; Chiang TT; Yang YS;
    J Chemother; 2022 May; 34(3):166-172. PubMed ID: 34818987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance.
    Rodriguez CH; Traglia G; Bastias N; Pandolfo C; Bruni G; Nastro M; Barrios R; Bavastro EM; Rey MC; Marques IA; Heger F; Vay C; Fernandez JS; Ramirez MS; Famiglietti A
    Int J Antimicrob Agents; 2019 Nov; 54(5):587-591. PubMed ID: 31400469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.
    Hawley JS; Murray CK; Jorgensen JH
    Antimicrob Agents Chemother; 2008 Jan; 52(1):351-2. PubMed ID: 17954699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate.
    Machado D; Antunes J; Simões A; Perdigão J; Couto I; McCusker M; Martins M; Portugal I; Pacheco T; Batista J; Toscano C; Viveiros M
    J Med Microbiol; 2018 Jun; 67(6):740-749. PubMed ID: 29717972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.
    Sherman EX; Wozniak JE; Weiss DS
    Methods Mol Biol; 2019; 1946():39-50. PubMed ID: 30798542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.